Literature DB >> 190330

Complement-fixing antigen of human cytomegaloviruses.

K S Kim, H M Moon, V J Sapienza, R I Carp.   

Abstract

The titer of complement-fixing (CF) antigen of human cytomegalovirus (CMV) strain C87 was not reduced by 10 cycles of freezing and thawing or by storage at 4 C for two months, although the virus was labile at 37 C and 100 C. The rapid increase in titers of CF antigen and plaque-forming units was seen from days 3 through 6 after infection; however, CF antigen was detected 24 hr after infection. The molecular weight of CF antigen was estimated by gel filtration to be greater than 1.5 X 10(7) daltons. Electrophoresis of CF antigens from five strains of human CMV (AD169, C87, Espilant [Esp.], Davis, and Towne) in a gradient polyacrylamide gel slab in the presence of sodium dodecyl sulfate revealed two specific polypeptides with molecular weights of 140,000 and 66,000 daltons, respectively. The smaller polypeptide was glycosylated. Preparations of CF antigen from murine CMV and herpes simplex virus type 1 contained polypeptides of 140,000 and 145,000 daltons, respectively. However, the polypeptide with a molecular weight of 66,000 daltons was seen only in preparations of human CMV.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 190330     DOI: 10.1093/infdis/135.2.281

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Confirmation of human cytomegalovirus by reverse passive hemagglutination with monoclonal antibodies reactive to the major glycosylated peptide (GP-66).

Authors:  K S Kim; V Sapienza; C M Chen
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

2.  Improved glycine-extracted complement-fixing antigen for human cytomegalovirus.

Authors:  J D Kettering; N J Schmidt; E H Lennette
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

3.  Production and characterization of monoclonal antibodies specific for a glycosylated polypeptide of human cytomegalovirus.

Authors:  K S Kim; V J Sapienza; C M Chen; K Wisniewski
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

4.  Mitogenic activity in human embryonic fibroblasts early after infection by human cytomegalovirus.

Authors:  N Takehara; K Ryoke; T Kurimura
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

Review 5.  Assessment of human cytomegalovirus antibody detection techniques.

Authors:  F Horodniceanu; S Michelson
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

6.  Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera.

Authors:  L Pereira; M Hoffman; N Cremer
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

7.  Longitudinal study of cytomegalovirus antibodies in individuals infected with the human immunodeficiency virus.

Authors:  R W Flø; G Haukenes; A Nilsen; R Skjaerven; M Forsgren; T E Fehniger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-06       Impact factor: 3.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.